Literature DB >> 17106184

Evolution of the diffuse neuroendocrine system--clear cells and cloudy origins.

Irvin M Modlin1, Manish C Champaneria, Jan Bornschein, Mark Kidd.   

Abstract

As early as the 2nd century, Galen proposed that 'vital spirits' in the blood regulated human bodily functions. However, the concept of hormonal activity required a further 18 centuries to develop and relied upon the identification of 'ductless glands', Schwann's cell and the recognition by Bayliss and Starling of chemical messengers. Bernard's introduction of 'internal secretion' and its role in homeostasis laid a physiological basis for the development of endocrinology. Kocher and Addison recognized the consequences of ablation of glands by disease or surgery and identified their necessary role in life. Detailed descriptions of the endocrine cells of the gut and pancreas and their putative function were provided by Heidenhain, Langerhans, Laguesse and Sharpey-Schafer. Despite the dominant 19th century concept of nervism (Pavlov), in 1902, Starling and Bayliss using Hardy's term 'hormonos' described secretin and in so doing, established the gut as an endocrine organ. Thus, nervism was supplanted by hormonal regulation of function and thereafter numerous bioactive gut peptides and amines were identified. At virtually the same time (1892), Ramón y Cajal of Madrid reported the existence of a group of specialized intestinal cells that he referred to as 'interstitial cells'. Cajal postulated that they might function as an interface between the neural system and the smooth muscles of the gut. Some 22 years later, Keith suggested that their function might be analogous to the electroconductive system of the heart and proposed their role as components of an intestinal pacemaker system. This prescient hypothesis was subsequently confirmed in 1982 by Thuneberg and a decade later Maede identified c-Kit as a critical molecular regulator in the development and function of the interstitial cells of Cajal and further confirmed the commonality of neural and endocrine cells. The additional characterization of the endocrine regulatory system of the GI tract was implemented when Feyrter (1938) using Masson's staining techniques, identified 'helle Zellen' within the pancreatic ductal system and the intestinal epithelium and proposed the concept of a diffuse neuroendocrine system. Pearse subsequently grouped the various cells belonging to that system under the rubric of a unifying APUD series. Currently, the gut neuroendocrine system is viewed as a syncytium of neural and endocrine cells sharing a common cell lineage whose phenotypic regulation is as yet unclear. Their key role in the regulation of gastrointestinal function is, however, indubitable.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17106184     DOI: 10.1159/000096997

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  15 in total

Review 1.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

Review 2.  Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications.

Authors:  Günter Klöppel
Journal:  Visc Med       Date:  2017-10-16

Review 3.  [Gastric neuroendocrine tumors. Endoscopic and surgical treatment].

Authors:  M B Niederle; B Niederle
Journal:  Chirurg       Date:  2011-07       Impact factor: 0.955

4.  Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.

Authors:  Pournima Navalkele; M Sue O'Dorisio; Thomas M O'Dorisio; Gideon K D Zamba; Charles F Lynch
Journal:  Pediatr Blood Cancer       Date:  2011-01       Impact factor: 3.167

5.  Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors.

Authors:  Amaury G Dumont; Yanwen Yang; David Reynoso; Daniela Katz; Jonathan C Trent; Dennis P Hughes
Journal:  Carcinogenesis       Date:  2012-07-04       Impact factor: 4.944

Review 6.  The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors.

Authors:  Mauro Cives; Jonathan Strosberg
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

Review 7.  Conserved genetic pathways controlling the development of the diffuse endocrine system in vertebrates and Drosophila.

Authors:  Volker Hartenstein; Shigeo Takashima; Katrina L Adams
Journal:  Gen Comp Endocrinol       Date:  2009-12-11       Impact factor: 2.822

Review 8.  Diagnostic value of circulating chromogranin a for neuroendocrine tumors: a systematic review and meta-analysis.

Authors:  Xin Yang; Yuan Yang; Zhilu Li; Chen Cheng; Ting Yang; Cheng Wang; Lin Liu; Shengchun Liu
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

9.  Oberndorfer and his successors: from carcinoid to neuroendocrine carcinoma.

Authors:  Günter Klöppel
Journal:  Endocr Pathol       Date:  2007       Impact factor: 4.056

10.  Large-Cell Neuroendocrine Carcinoma of the Esophagus: A Case from Saudi Arabia.

Authors:  Hadi Kuriry; Abdul Monem Swied
Journal:  Case Rep Gastroenterol       Date:  2015-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.